![](/img/cover-not-exists.png)
Identification of on-target mutagenesis during correction of a beta-thalassemia splice mutation in iPS cells with optimised CRISPR/Cas9-double nickase reveals potential safety concerns
Alateeq, Suad, Ovchinnikov, Dmitry, Tracey, Timothy, Whitworth, Deanne, Al-Rubaish, Abdullah, Al-Ali, Amein, Wolvetang, ErnstVolume:
2
Journal:
APL Bioengineering
DOI:
10.1063/1.5048625
Date:
December, 2018
File:
PDF, 1.35 MB
2018